Episurf Medical AB (publ) (STO:EPIS.B)
Sweden
· Delayed Price · Currency is SEK 0.0480
-0.0015 (-3.03%)
Mar 9, 2026, 5:29 PM CET
Episurf Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 20.2 | 20.6 | 19.8 | 6.6 | 6.5 | Upgrade
|
| Revenue | 20.2 | 20.6 | 19.8 | 6.6 | 6.5 | Upgrade
|
| Revenue Growth (YoY) | -1.94% | 4.04% | 200.00% | 1.54% | 30.00% | Upgrade
|
| Cost of Revenue | 10.1 | 52.4 | 61.6 | 36.2 | 35 | Upgrade
|
| Gross Profit | 10.1 | -31.8 | -41.8 | -29.6 | -28.5 | Upgrade
|
| Selling, General & Admin | 30.9 | 36.5 | 46.6 | 40.3 | 34 | Upgrade
|
| Other Operating Expenses | 28.9 | -0.1 | -0.3 | -0.3 | -0.4 | Upgrade
|
| Operating Expenses | 67.9 | 45.4 | 55 | 47.4 | 41 | Upgrade
|
| Operating Income | -57.8 | -77.2 | -96.8 | -77 | -69.5 | Upgrade
|
| Interest Expense | -0.6 | -1 | -0.9 | -0.7 | -0.2 | Upgrade
|
| Interest & Investment Income | 0.5 | 2.2 | 3.1 | 0.5 | 0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.1 | 0.1 | - | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | -57.9 | -75.9 | -94.5 | -77.2 | -69.4 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.1 | Upgrade
|
| Pretax Income | -57.9 | -75.9 | -94.5 | -77.2 | -69.3 | Upgrade
|
| Income Tax Expense | 0.3 | 0.1 | 0.3 | 0.1 | - | Upgrade
|
| Net Income | -58.2 | -76 | -94.8 | -77.3 | -69.3 | Upgrade
|
| Net Income to Common | -58.2 | -76 | -94.8 | -77.3 | -69.3 | Upgrade
|
| Shares Outstanding (Basic) | 987 | 495 | 314 | 267 | 227 | Upgrade
|
| Shares Outstanding (Diluted) | 987 | 495 | 314 | 267 | 227 | Upgrade
|
| Shares Change (YoY) | 99.37% | 57.49% | 17.84% | 17.67% | 39.80% | Upgrade
|
| EPS (Basic) | -0.06 | -0.15 | -0.30 | -0.29 | -0.31 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.15 | -0.30 | -0.29 | -0.31 | Upgrade
|
| Free Cash Flow | -55.3 | -71.4 | -84.8 | -69.5 | -59.8 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.14 | -0.27 | -0.26 | -0.26 | Upgrade
|
| Gross Margin | 50.00% | -154.37% | -211.11% | - | - | Upgrade
|
| Operating Margin | -286.14% | -374.76% | -488.89% | -1166.67% | -1069.23% | Upgrade
|
| Profit Margin | -288.12% | -368.93% | -478.79% | -1171.21% | -1066.15% | Upgrade
|
| Free Cash Flow Margin | -273.76% | -346.60% | -428.28% | -1053.03% | -920.00% | Upgrade
|
| EBITDA | -52.2 | -74.1 | -94.1 | -74.4 | -66.6 | Upgrade
|
| EBITDA Margin | -258.42% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 5.6 | 3.1 | 2.7 | 2.6 | 2.9 | Upgrade
|
| EBIT | -57.8 | -77.2 | -96.8 | -77 | -69.5 | Upgrade
|
| EBIT Margin | -286.14% | - | - | - | - | Upgrade
|
| Revenue as Reported | 22.8 | 20.7 | 20.1 | 18.2 | 13.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.